Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

The Outcomes of Nivolumab Fixed Dose 40 Mg Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Liudmila Fedorova, Kirill Lepik, Polina Kotselyabina, Elena Kondakova, Yuri Zalyalov, Evgeniya Borzenkova, Vadim Baykov, Olga S. Epifanovskaya, Elena V. Babenko, Ivan S. Moiseev, Aleksander Kulagin, Natalia Mikhailova, Boris Afanasyev

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-136620

Published: 2020

Journal Articles

Evolution of Outcome over Time for Relapsed Hodgkin Lymphoma after Autologous Stem Cell Transplant: Improved Survival for Early Relapse in Recent Years

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-138546

Published: 2020

Journal Articles

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Blood (2019) 134 (Supplement_2): LBA-3.

https://doi.org/10.1182/blood-2019-132405

Published: 2019

Journal Articles

Safety and Efficacy of Allogeneic Stem Cell Transplantation after PD-1 Blockade for Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

Anastasiya V Beynarovich, MD, Kirill Lepik, Nataliia Mikhailova, Elena Kondakova, Yuri Zalaylov, Evgeniya Borzenkova, Elena Babenko, Elena I Darskaya, MD PhD, Ivan S Moiseev, MD PhD, Axel Zander, Boris Afanasyev

Blood (2019) 134 (Supplement_1): 1561.

https://doi.org/10.1182/blood-2019-129076

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 148.

https://doi.org/10.1182/blood-2019-123269

Published: 2019

Journal Articles

Long-Term Durability of Eltrombopag Clinical Benefit for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia (ASPIRE Part 3)

Moshe Mittelman, MD, Uwe Platzbecker, MD, Boris Afanasyev, MD PhD, Sebastian Grosicki, MD PhD, Maria Socorro O Portella, MD MBA, Zewen Zhu, Dominik Selleslag, MD

Blood (2019) 134 (Supplement_1): 3740.

https://doi.org/10.1182/blood-2019-130309

Published: 2019

Journal Articles

Comparison of Allogeneic Transplant Outcomes Using Conditioning with Different Dose of Busulfan for Children with Acute Myeloid Leukemia

Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Polina Valerievna Kozhokar, Dr., Anastasia S Frolova, Dr, Kirill Alexandrovich Ekushov, Dr., Luibov Tsvetkova, Tatiana A Bykova, MD PhD, Inna V Markova, Dr., Sergey N. Bondarenko, PhDMD, Ildar M Barkhatov, MD PhD, Aleksandr Alyanski, Elena Babenko, Ivan S Moiseev, MD PhD, Marina O Popova, MD PhD, Elena Vladimirovna Semenova, MD PhD, Ludmila S Zubarovskaya, MD PhD professor, Axel Zander, Boris Afanasyev

Blood (2019) 134 (Supplement_1): 4510.

https://doi.org/10.1182/blood-2019-128155

Published: 2019

Journal Articles

Graft-Versus Host Disease Prophylaxis with Postransplantation Bendamustine in Refractory Leaukemia Patients

Ivan S Moiseev, MD PhD, Sergey N. Bondarenko, PhDMD, Elena I Darskaya, MD PhD, Aleksandr Alyanski, Evgeniya Borzenkova, Anna Dotcenko, Olga Kudyasheva, MD, Sergey Lapin, MD PhD, Elena Surkova, PhD, Varvara Nikolaevna Ovechkina, Olga Vladislavovna Pirogova, MD PhD, Valentina Vladimirovna Porunova, MD, Axel Zander, Boris Afanasyev

Blood (2019) 134 (Supplement_1): 5746.

https://doi.org/10.1182/blood-2019-125570

Published: 2019

Journal Articles

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

Giorgia Battipaglia, Myriam Labopin, Nicolaus Kröger, Antonin Vitek, Boris Afanasyev, Inken Hilgendorf, Johannes Schetelig, Arnold Ganser, Didier Blaise, Maija Itälä-Remes, Jakob R. Passweg, Francesca Bonifazi, Jurgen Finke, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty

Blood (2019) 134 (11): 892–899.

https://doi.org/10.1182/blood.2019000487

Published: 2019

Includes: Supplemental data

Journal Articles

Benefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia

Aleksandr Kulagin, Olesya Klimova, Tatiana Rudakova, Irina Golubovskaya, Maria Ivanova, Anna Smirnova, Alexandra Lapina, Tatiana Bykova, Elena Babenko, Marina Popova, Vladimir Dobronravov, Boris Afanasyev

Blood (2018) 132 (Supplement 1): 2589.

https://doi.org/10.1182/blood-2018-99-120139

Published: 2018

Journal Articles

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Blood (2018) 132 (Supplement 1): 486.

https://doi.org/10.1182/blood-2018-99-114033

Published: 2018

Journal Articles

Hematopoietic Stem Cell Transplantation for CNS Autoimmune Disorders for Adults and Children: Long-Term Outcomes - Experience of the Russian Federation

Kirill Kirgizov, Elena Skorobogatova, Denis Fedorenko, Elvira Volkova, Alexey Polushin, Ekaterina Pristanskova, Oksana Blagonravova, Sergey Piliya, Raisa Bembeeva, Ludmila Zubarovskaya, Axel Zander, Boris Afanasyev, Alexander Rumyantsev

Blood (2018) 132 (Supplement 1): 5752.

https://doi.org/10.1182/blood-2018-99-118711

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Noga Shem-Tov, MD, Christophe Peczynski, Myriam Labopin, MD, Maija Itälä-Remes, MD PhD, Didier Blaise, Hélène Labussière-Wallet, Gérard Socié, MDPhD, Nicolaus Kröger, MD, Per Ljungman, MD PhD, Boris Afanasyev, Patrice Chevallier, MD, Johanna Tischer, Grzegorz Helbig, Pavel Jindra, MD PhD, Sebastian Giebel, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 2174.

https://doi.org/10.1182/blood-2018-99-111604

Published: 2018

Journal Articles

The Pregnancy Course and Outcomes during Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria

Maria A. Vinogradova, MD, Alexandr Kulagin, MD, PhD, Roman Shmakov, MD PhD, Tatyana Kirsanova, MD, Elena Mikhailova, MD PhD, Olesya Klimova, MD, Alexandr Korobkin, MD, Boris Afanasyev, MD PhD

Blood (2016) 128 (22): 2397.

https://doi.org/10.1182/blood.V128.22.2397.2397

Published: 2016

Journal Articles

Prognostic Impact of Adverse Chromosomal Abnormalities on Outcome of Allogeneic Stem Cell Transplantation in Hyperdiploid Variant of Acute Myeloid Leukemia

Tatiana L Gindina, MD PhD, Mamaev N Nikolay, Prof., Bondarenko N Sergey, MD PhD, Slesarchuk A Olga, MD PhD, Anastasiya S Borovkova, MD, Svetlana V Razumova, MD, Zubarovskaya S Lyudmila, Prof., Boris Afanasyev, Prof.

Blood (2016) 128 (22): 5234.

https://doi.org/10.1182/blood.V128.22.5234.5234

Published: 2016

Journal Articles

Incidence, Clinical Characteristics and Outcome of Symptomatic Thromboembolic Events (TE) in 276 Patients with Paroxysmal Nocturnal Hemoglobinurea (PNH)

Alexander Kulagin, Prof., Olesya Klimova, MD, Alexey Dobronravov, MD, Elena Pavlyuchenko, MD, Elena Babenko, MD, Vladimir Dobronravov, Prof., Boris Afanasyev, Prof.

Blood (2016) 128 (22): 5072.

https://doi.org/10.1182/blood.V128.22.5072.5072

Published: 2016

Journal Articles

Use of First or Second Generation TKI for CML after Allogeneic Stem Cell Transplantation: a Study By the CMWP of the EBMT

Blood (2016) 128 (22): 4685.

https://doi.org/10.1182/blood.V128.22.4685.4685

Published: 2016

Journal Articles

Efficacy, Safety and Long Term Results of Prophylactic and Preemptive Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Acute Leukemia: A Registry-Based Evaluation on 343 Patients By the Acute Leukemia Working Party of EBMT

Blood (2015) 126 (23): 863.

https://doi.org/10.1182/blood.V126.23.863.863

Published: 2015

Journal Articles

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

Blood (2015) 126 (16): 1885–1892.

https://doi.org/10.1182/blood-2015-02-628859

Published: 2015

Journal Articles

Long-Term Outcomes of Accelerated Telomere Shortening in Acquired Aplastic Anemia

Alexander Kulagin, Vyacheslav Borisov, Natalia Pronkina, Irina Kruchkova, Igor Lisukov, Boris Afanasyev

Blood (2014) 124 (21): 4396.

https://doi.org/10.1182/blood.V124.21.4396.4396

Published: 2014

NARROW

The Outcomes of Nivolumab Fixed Dose 40 Mg Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Evolution of Outcome over Time for Relapsed Hodgkin Lymphoma after Autologous Stem Cell Transplant: Improved Survival for Early Relapse in Recent Years

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Safety and Efficacy of Allogeneic Stem Cell Transplantation after PD-1 Blockade for Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Long-Term Durability of Eltrombopag Clinical Benefit for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia (ASPIRE Part 3)

Comparison of Allogeneic Transplant Outcomes Using Conditioning with Different Dose of Busulfan for Children with Acute Myeloid Leukemia

Graft-Versus Host Disease Prophylaxis with Postransplantation Bendamustine in Refractory Leaukemia Patients

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

Benefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Hematopoietic Stem Cell Transplantation for CNS Autoimmune Disorders for Adults and Children: Long-Term Outcomes - Experience of the Russian Federation

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

The Pregnancy Course and Outcomes during Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria

Prognostic Impact of Adverse Chromosomal Abnormalities on Outcome of Allogeneic Stem Cell Transplantation in Hyperdiploid Variant of Acute Myeloid Leukemia

Incidence, Clinical Characteristics and Outcome of Symptomatic Thromboembolic Events (TE) in 276 Patients with Paroxysmal Nocturnal Hemoglobinurea (PNH)

Use of First or Second Generation TKI for CML after Allogeneic Stem Cell Transplantation: a Study By the CMWP of the EBMT

Efficacy, Safety and Long Term Results of Prophylactic and Preemptive Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Acute Leukemia: A Registry-Based Evaluation on 343 Patients By the Acute Leukemia Working Party of EBMT

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

Long-Term Outcomes of Accelerated Telomere Shortening in Acquired Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only